Pediatric Blood & Cancer · 2006 · 57 citations · 9 references
ImmunologyChronic ItpFuture DevelopmentImmunotherapyLater DevelopmentHematologyRheumatoid ArthritisHealth SciencesRheumatologyAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupus NephritisAutoimmunityPaediatric RheumatologySclerodermaRisk FactorsInborn Error Of ImmunityLupusPediatricsMedicine
The risk of later development of systemic lupus erythematosus (SLE) in childhood idiopathic thrombocytopenic purpura (ITP) is currently unknown. We retrospectively evaluated the incidence and risk factors of this complication in 222 children with ITP who were followed for a mean of 4.2+/-4.9 years. During that time 3.6% of the children (8/222) developed SLE; all were females with positive anti-nuclear antibody (ANA), older (12.7+/-3.6 vs. 6.4+/-4.3 years old; P<0.01), and were more likely to have chronic ITP (87.5 vs. 46%; P=0.02), and had high titers of ANA. The majority of children with ITP who had a positive ANA (14/22, 64%) did not develop SLE.
9
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations
Diagnosis, Pathology, Dermatology +19
Hematology of Infancy and Childhood.
Annals of Internal Medicine · 1975 · 893 citations
Hematology of Infancy and Childhood
Ruth Andrea Seeler · JAMA · 1981 · 203 citations
Intracranial hemorrhage in children with immune thrombocytopenic purpura
H Iyori, Fumio Bessho, H. Ookawa et al. · Annals of Hematology · 2000 · 76 citations
Thrombosis, Intracranial Hemorrhage, Pediatric Hematology +10